The United States dominates globally in insulin exports, holding the largest share, with Denmark as a distant second. India has increasingly contributed significantly, reflecting strong demand growth. Notable positive trends are observed for Singapore, UAE, and the UK with their over 6% year-on-year growth. Contrarily, significant declines are seen in France and Japan, representing a market contraction for these players.
Looking forward, watch for India's expanding market share driven by cost-effective production, and potential impacts of healthcare policy changes in major markets. The growing demand in emerging economies may shift the balance in global export dynamics over the next few years.
Top countries in Export of Insulin Share by Country (US Dollars)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 76.21 | 2023 | +3.01% | +2.92% | View data |
| 2 | 2 Denmark | 17.4 | 2023 | -3.1% | +0.21% | View data |
| 3 | 3 India | 1.74 | 2023 | +2.77% | +5.53% | View data |
| 4 | 4 France | 0.95 | 2023 | -2.98% | -6.36% | View data |
| 5 | 5 Malaysia | 0.83 | 2023 | +6.53% | +3.91% | View data |
| 6 | 6 China | 0.79 | 2023 | +1.82% | +0.28% | View data |
| 7 | 7 Portugal | 0.31 | 2023 | +6.04% | +2.94% | View data |
| 8 | 8 Netherlands | 0.29 | 2023 | -2.62% | -3.59% | View data |
| 9 | 9 Singapore | 0.21 | 2023 | +5.47% | +14.65% | View data |
| 10 | 10 United Arab Emirates | 0.085 | 2023 | +4.68% | +6.02% | View data |
